AlphaMark Advisors LLC Cuts Holdings in Molina Healthcare, Inc. (NYSE:MOH)

AlphaMark Advisors LLC lessened its stake in Molina Healthcare, Inc. (NYSE:MOH) by 3.0% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 3,503 shares of the company’s stock after selling 108 shares during the quarter. AlphaMark Advisors LLC’s holdings in Molina Healthcare were worth $1,439,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in MOH. Desjardins Global Asset Management Inc. lifted its holdings in Molina Healthcare by 4.4% during the 4th quarter. Desjardins Global Asset Management Inc. now owns 763 shares of the company’s stock worth $276,000 after buying an additional 32 shares during the last quarter. Ritholtz Wealth Management boosted its holdings in Molina Healthcare by 2.1% in the fourth quarter. Ritholtz Wealth Management now owns 1,620 shares of the company’s stock valued at $585,000 after purchasing an additional 33 shares in the last quarter. GAMMA Investing LLC increased its stake in Molina Healthcare by 11.5% in the first quarter. GAMMA Investing LLC now owns 330 shares of the company’s stock valued at $136,000 after purchasing an additional 34 shares during the last quarter. Raleigh Capital Management Inc. raised its holdings in Molina Healthcare by 40.4% during the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after purchasing an additional 36 shares in the last quarter. Finally, Brighton Jones LLC raised its holdings in Molina Healthcare by 1.1% during the fourth quarter. Brighton Jones LLC now owns 3,357 shares of the company’s stock worth $1,213,000 after purchasing an additional 37 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Molina Healthcare

In other news, Director Ronna Romney sold 250 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the transaction, the director now owns 16,945 shares in the company, valued at approximately $5,816,710.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Molina Healthcare news, COO James Woys sold 10,000 shares of the business’s stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the sale, the chief operating officer now directly owns 53,613 shares in the company, valued at $18,504,526.95. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Ronna Romney sold 250 shares of the company’s stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the sale, the director now directly owns 16,945 shares in the company, valued at approximately $5,816,710.15. The disclosure for this sale can be found here. Company insiders own 1.11% of the company’s stock.

Molina Healthcare Stock Performance

Shares of MOH stock traded down $5.14 during mid-day trading on Monday, hitting $292.16. The stock had a trading volume of 409,723 shares, compared to its average volume of 432,734. The firm has a market cap of $17.12 billion, a PE ratio of 15.85, a PEG ratio of 0.91 and a beta of 0.58. The company’s 50-day simple moving average is $326.83 and its 200-day simple moving average is $362.37. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. Molina Healthcare, Inc. has a fifty-two week low of $288.79 and a fifty-two week high of $423.92.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The firm had revenue of $9.93 billion during the quarter, compared to the consensus estimate of $9.45 billion. During the same quarter last year, the firm earned $5.81 earnings per share. The firm’s revenue was up 21.9% compared to the same quarter last year. Sell-side analysts anticipate that Molina Healthcare, Inc. will post 23.56 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts recently commented on MOH shares. Baird R W raised shares of Molina Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reissued an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a report on Thursday, April 4th. Robert W. Baird assumed coverage on Molina Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $405.00 price target on the stock. Bank of America cut Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price objective for the company. in a research note on Thursday, March 28th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Molina Healthcare from $435.00 to $420.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $407.45.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.